Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactulose vs sennoside for prevention of bacterial peritonitis in peritoneal dialysis patients
TCTR20171012001Phase 3Completed
- Sponsor
- Chiang Mai University
- Start
- Jun 2017
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lactulose, sennosid A + sennosid B in peritonitis, end-stage kidney disease (ESKD), sponsored by Chiang Mai University. Started Jun 2017; status: completed.
02
Drugs
lactulosesennosid A + sennosid B
03
Conditions
peritonitisend-stage kidney disease (ESKD)
Beyond the preview
Go deeper on TCTR20171012001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20171012001.